Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aureobasidium pullulans is a ubiquitous, black, yeast-like fungus. [5] It is not a therapeutic drug but has several medically-related applications. Primarily, it is classified as a Non-Standardized Fungal Allergenic Extract used for diagnostic purposes in allergy testing. [7] In this context, the extract is used to provoke an immune response in individuals to test for allergies to the mold. [7] The fungus itself can be an opportunistic pathogen, causing a range of infections in humans, and exposure can also lead to hypersensitivity pneumonitis. [1, 5, 15] Additionally, A. pullulans is a source of various bioactive compounds. It is fermented to produce beta-glucans, which are sold as dietary supplements for their purported immunomodulatory activities, such as enhancing immune function and supporting intestinal health. [3, 6, 14] The fungus is also used for the industrial production of pullulan, a biodegradable polysaccharide with applications in the food, cosmetic, and pharmaceutical industries. [13, 20]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aureobasidium pullulans var. pullutans.